KML001, a Telomere-Targeting Drug, Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy and Radiotherapy through DNA Damage and Apoptosis
Seon Rang Woo(Samsung Medical Center), Do‐Hyun Nam(Samsung (South Korea))
Cited by 23
Related Papers
Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells
|Cell Death and Disease|2018|66